BioAdaptives, Inc. (BDPT)
OTCMKTS · Delayed Price · Currency is USD
0.0017
-0.0001 (-5.56%)
At close: Oct 19, 2026
BioAdaptives Revenue
BioAdaptives had revenue of $4.99K in the quarter ending June 30, 2026, with 54.95% growth. This brings the company's total for the last twelve months to $25.56K, up 694.07% year-over-year. In the year 2025, BioAdaptives had annual revenue of $18.28K with 44.27% growth. That makes BioAdaptives the 46,906th largest company in the world by revenue and 7,063rd in the United States.
Revenue (ttm)
25.56K
Revenue Growth
+694.07%
P/S Ratio
12.33
Revenue / Employee
25.56K
Employees
1
Market Cap
315.08K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 18.28K | 5.61K | 44.27% |
| Dec 31, 2024 | 12.67K | -15.90K | -55.65% |
| Dec 31, 2023 | 28.57K | 11.39K | 66.31% |
| Dec 31, 2022 | 17.18K | -2.60K | -13.15% |
| Dec 31, 2021 | 19.78K | 3.45K | 21.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ayujoy Herbals | 70.87M |
| Amincor | 23.56M |
| Oriental Rise Holdings | 12.22M |
| Functional Brands | 6.70M |
| Energy Today | 846.81K |
| Tradewinds Universal | 147.05K |
| NuVim | 60.02K |
| Hi-Great Group Holding Company | 38.15K |
BioAdaptives News
- 27 days ago - BioAdaptives Highlights Michael Bisping's MyndMed(TM) Routine in UFC 331 Pre-Show Instagram Video - Accesswire
- 6 weeks ago - BioAdaptives Confirms First Commercial Orders of XcellaraHeart(TM) and Outlines Capital Restructuring Progress - Accesswire
- 7 weeks ago - UFC Hall of Famer Michael Bisping Joins BioAdaptives to Champion MyndSystem(TM) - Accesswire
- 2 months ago - BioAdaptives, Inc. Announces CEO's Share Cancellation and Provides Capital Restructure Update - Accesswire
- 2 months ago - BioAdaptives Inc. Introduces XcellaraHeart(TM): the World's First Stem Cell Mobilizer with a Targeted Cardiac Homing Signal - Accesswire
- 2 months ago - BioAdaptives Inc. Opens Commercial Ordering Window for XcellaraHeart(TM) Cellular Wellness Formula - Accesswire
- 2 months ago - BioAdaptives Inc. Eliminates Major Market Overhang by Retiring the Debt of the Largest Convertible Commercial Investor - Accesswire
- 2 months ago - BioAdaptives Inc. Reports Scaling of E-Commerce Footprint and Consumer Reach for MyndSystem(TM) Nootropic Platform - Accesswire